US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 6.970
  • +0.260+3.87%
Trading Feb 27 15:27 ET
793.54MMarket Cap-3.59P/E (TTM)

Cogent Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
32.58%275.94M
26.63%73.73M
26.58%75.41M
36.75%64.39M
44.33%62.4M
40.78%208.13M
33.11%58.23M
61.81%59.58M
31.32%47.09M
37.62%43.24M
Selling and administrative expenses
25.91%43.28M
22.93%11.69M
24.83%11.8M
22.88%10.09M
34.73%9.7M
31.14%34.38M
35.78%9.51M
37.30%9.45M
28.83%8.21M
21.03%7.2M
-General and administrative expense
25.91%43.28M
22.93%11.69M
24.83%11.8M
22.88%10.09M
34.73%9.7M
31.14%34.38M
35.78%9.51M
37.30%9.45M
28.83%8.21M
21.03%7.2M
Research and development costs
33.90%232.66M
27.35%62.05M
26.91%63.61M
39.68%54.29M
46.25%52.71M
42.86%173.76M
32.60%48.72M
67.45%50.13M
31.86%38.87M
41.49%36.04M
Operating profit
-32.58%-275.94M
-26.63%-73.73M
-26.58%-75.41M
-36.75%-64.39M
-44.33%-62.4M
-40.78%-208.13M
-33.11%-58.23M
-61.81%-59.58M
-31.32%-47.09M
-37.62%-43.24M
Net non-operating interest income expense
38.32%18.09M
-0.28%3.86M
13.84%4.78M
96.75%5.39M
78.88%4.06M
227.83%13.08M
83.41%3.87M
179.87%4.2M
907.72%2.74M
2,019.63%2.27M
Non-operating interest income
38.32%18.09M
-0.28%3.86M
13.84%4.78M
96.75%5.39M
78.88%4.06M
227.83%13.08M
83.41%3.87M
179.87%4.2M
907.72%2.74M
2,019.63%2.27M
Other net income (expense)
-24.63%1.99M
27,928.57%1.95M
1K
-83.58%44K
-100.04%-1K
-26.77%2.64M
-100.35%-7K
-59.15%268K
251.85%2.38M
Other non- operating income (expenses)
-24.63%1.99M
27,928.57%1.95M
--1K
-83.58%44K
-100.04%-1K
-26.77%2.64M
-100.35%-7K
----
-59.15%268K
251.85%2.38M
Income before tax
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
Income tax
Net income
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
Net income continuous Operations
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
Minority interest income
Net income attributable to the parent company
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-32.98%-255.86M
-24.95%-67.93M
-27.54%-70.63M
-33.75%-58.95M
-51.21%-58.35M
-37.20%-192.41M
-37.22%-54.37M
-57.95%-55.38M
-26.19%-44.08M
-25.96%-38.59M
Basic earnings per share
0.00%-1.94
2.39%-0.6149
0.00%-0.64
0.00%-0.59
-12.73%-0.62
-12.14%-1.94
-12.50%-0.63
-28.00%-0.64
16.90%-0.59
19.12%-0.55
Diluted earnings per share
0.00%-1.94
2.39%-0.6149
0.00%-0.64
0.00%-0.59
-12.73%-0.62
-12.14%-1.94
-12.50%-0.63
-28.00%-0.64
16.90%-0.59
19.12%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 32.58%275.94M26.63%73.73M26.58%75.41M36.75%64.39M44.33%62.4M40.78%208.13M33.11%58.23M61.81%59.58M31.32%47.09M37.62%43.24M
Selling and administrative expenses 25.91%43.28M22.93%11.69M24.83%11.8M22.88%10.09M34.73%9.7M31.14%34.38M35.78%9.51M37.30%9.45M28.83%8.21M21.03%7.2M
-General and administrative expense 25.91%43.28M22.93%11.69M24.83%11.8M22.88%10.09M34.73%9.7M31.14%34.38M35.78%9.51M37.30%9.45M28.83%8.21M21.03%7.2M
Research and development costs 33.90%232.66M27.35%62.05M26.91%63.61M39.68%54.29M46.25%52.71M42.86%173.76M32.60%48.72M67.45%50.13M31.86%38.87M41.49%36.04M
Operating profit -32.58%-275.94M-26.63%-73.73M-26.58%-75.41M-36.75%-64.39M-44.33%-62.4M-40.78%-208.13M-33.11%-58.23M-61.81%-59.58M-31.32%-47.09M-37.62%-43.24M
Net non-operating interest income expense 38.32%18.09M-0.28%3.86M13.84%4.78M96.75%5.39M78.88%4.06M227.83%13.08M83.41%3.87M179.87%4.2M907.72%2.74M2,019.63%2.27M
Non-operating interest income 38.32%18.09M-0.28%3.86M13.84%4.78M96.75%5.39M78.88%4.06M227.83%13.08M83.41%3.87M179.87%4.2M907.72%2.74M2,019.63%2.27M
Other net income (expense) -24.63%1.99M27,928.57%1.95M1K-83.58%44K-100.04%-1K-26.77%2.64M-100.35%-7K-59.15%268K251.85%2.38M
Other non- operating income (expenses) -24.63%1.99M27,928.57%1.95M--1K-83.58%44K-100.04%-1K-26.77%2.64M-100.35%-7K-----59.15%268K251.85%2.38M
Income before tax -32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M
Income tax
Net income -32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M
Net income continuous Operations -32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M
Minority interest income
Net income attributable to the parent company -32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -32.98%-255.86M-24.95%-67.93M-27.54%-70.63M-33.75%-58.95M-51.21%-58.35M-37.20%-192.41M-37.22%-54.37M-57.95%-55.38M-26.19%-44.08M-25.96%-38.59M
Basic earnings per share 0.00%-1.942.39%-0.61490.00%-0.640.00%-0.59-12.73%-0.62-12.14%-1.94-12.50%-0.63-28.00%-0.6416.90%-0.5919.12%-0.55
Diluted earnings per share 0.00%-1.942.39%-0.61490.00%-0.640.00%-0.59-12.73%-0.62-12.14%-1.94-12.50%-0.63-28.00%-0.6416.90%-0.5919.12%-0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Disney
DIS
-0.20%
Cisco
CSCO
-0.44%
Apple
AAPL
-0.49%
Adobe
ADBE
-0.54%
Microsoft
MSFT
-1.38%

Unlock the Full List